CCL19 overexpression

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.

CCL19 overexpression	Melanoma	CCL19 overexpression	Melanoma	ipilimumab Sensitive: C3 – Early Trials ipilimumab Sensitive : C3	ipilimumab Sensitive: C3 – Early Trials ipilimumab Sensitive : C3
CCL19 overexpression	Follicular Lymphoma	CCL19 overexpression	Follicular Lymphoma	rituximab Sensitive: C3 – Early Trials rituximab Sensitive : C3	rituximab Sensitive: C3 – Early Trials rituximab Sensitive : C3

Associations